Analysis: Investors weigh chaos as high court reviews health law
NEW YORK At Aetna Inc's headquarters in Hartford, Connecticut, about two dozen employees devote all their working hours to one task: making sure the health insurer is up to speed with President Barack Obama's U.S. healthcare overhaul law.
On a part-time basis, more than 1,000 more employees are also working daily on activities tied to the overhaul as the No. 3 U.S. health insurer seeks to comply with the regulations and communicates the changes to its thousands of customers.
In 2010 alone, Aetna says it invested 53,000 work hours -- the equivalent of one person working for 25 years -- updating computer systems to accommodate the new benefits and changes in the law.
"This is touching every different type of business we have," Kay Mooney, Aetna's head of strategic development and product who is helping oversee the company's overhaul efforts, said in an interview. "We need to think about it in all respects."
What if all the work is for naught? That possibility comes into high relief for the healthcare industry starting on Monday, when the U.S. Supreme Court begins hearing arguments about the healthcare overhaul law.
And it has investors and analysts attempting to handicap fallout from the high-profile decision. Shares of large health insurers appear to face little significant downside should the law be entirely tossed out or upheld -- at least in the near term. The major risk lies with a decision that strikes down just the part of the law that requires people to buy coverage.
The court is expected to rule by late June on the law -- Obama's signature domestic policy achievement enacted two years ago that is set to extend health coverage to more than 30 million uninsured Americans. The law is being challenged by 26 states and an independent business group.
At the heart of the court debate is the portion that requires individuals to buy health insurance or pay a penalty. Should the court strike down that requirement, known as the individual mandate, and deem it unseverable from the rest of the law, the entire legislation would be invalidated.
"We will have chaos," said Timothy Jost, a law professor who focuses on healthcare at the Washington and Lee University School of Law in Virginia.
Such chaos may not be bad news for investors in the short term. Many healthcare analysts say shares of large insurers, such as Aetna, UnitedHealth Group Inc and WellPoint Inc stand to immediately jump at least 5 percent should the court strike down the legislation as a whole.
Others see a more modest insurer share rally possible if the law is upheld as a decision will provide more certainty over how the companies will do business. But most agree that a partial ruling that tosses out just the individual mandate could be disastrous for the stocks.
The law's regulations put greater scrutiny on the insurance premium increases that help fuel industry profits. They require insurers to spend at least 80 percent of their premiums on medical costs as opposed to administrative expenses and impose higher fees on their insurance plans in the years ahead.
"The best case is if the whole thing gets thrown out," said Tim Nelson, healthcare analyst with Nuveen Asset Management.
But that sentiment has not been shared by many insurance executives since the law was passed in 2010. Several have expressed their opposition to Republican efforts to repeal the law. If the Supreme Court shoots it down now, the problems of Americans lacking insurance and the country's rising healthcare costs will remain -- possibly forcing government to intervene with far more onerous regulations on the industry in the future.
"What the marketplace needs is some certainty as to where healthcare reform is going," said Robert Laszewski, who consults for health insurers as president of Health Policy and Strategy Associates. "And while the Obama health law is so imperfect and flawed in so many ways, it gave us a target and it said here's where we're going to be for the next 10 or 20 years."
Among other industries, shares of hospital chains, such as HCA Holdings Inc and Tenet Healthcare Inc, are expected to drop steeply should the law be struck down because they would stand to lose millions of insured customers.
Such a ruling is poised to boost shares of medical device manufacturers, such as Boston Scientific, which face taxes on sales of their products under the law.
STATUS QUO SEEN LIKELY
In an American Bar Association poll of a small group of influential academics, journalists and lawyers who follow the Supreme Court, 85 percent predicted the law would be upheld.
More than 70 percent of 200 investors queried by Goldman Sachs in January also speculated that a decision to uphold the law would be the most likely outcome.
Still, shares of health insurers could rise modestly should the law win backing. Some investors may have held off on the sector until the court's decision provides more certainty.
"If it's status quo, there's probably a rally," said Les Funtleyder, a portfolio manager and healthcare strategist with Miller Tabak. "It's probably also a rally for hospitals too."
The worst-case scenario for health insurers is if the court strikes down the individual mandate but leaves the rest of the law standing. Wall Street experts see this as unlikely.
The law requires insurers to offer coverage regardless of health status, including pre-existing medical conditions. To counter the likely influx of sick, high-cost policyholders, insurers say the individual mandate is necessary to ensure that healthy people are also in the insurance pool.
If only the mandate is struck down, many people may only buy insurance when they become ill, said Justine Handelman, vice president of legislative and regulatory policy for the Blue Cross and Blue Shield Association.
"It's akin to saying you can buy your homeowners insurance when you smell smoke," Handelman said. "That will cause premiums to go up for everyone."
Health insurer stocks would also tumble, possibly more than 5 percent, said David Heupel, senior healthcare analyst at Thrivent Investment Management.
The court is also weighing whether the federal government unconstitutionally forced the states to expand the Medicaid program to millions more low-income Americans under the law.
The expansion could provide an important growth opportunity for some big players like UnitedHealth as well as smaller insurers that specialize in Medicaid, such as Amerigroup, Molina Healthcare and Centene.
"We believe Medicaid's expansion ... is the one that carries a meaningful risk of being overturned," analysts at Jefferies & Co said in a recent research note. "Such a decision would be a meaningful negative for most healthcare service stocks, especially acute care providers and managed Medicaid companies."
Meanwhile, Aetna and other insurers continue to operate as if the law will stay in place -- unless they learn otherwise.
"We have strategies ready for whatever happens over the next 18 months," Mooney said.
(Editing by Michele Gershberg; desking by Mark Porter)
NEW YORK At Aetna Inc's headquarters in Hartford, Connecticut, about two dozen employees devote all their working hours to one task: making sure the health insurer is up to speed with President Barack Obama's U.S. healthcare overhaul law. On a part-t
PENSACOLA, Florida Attorneys for the Obama administration and 20 U.S. states sparred in court on Thursday over whether the new healthcare law oversteps constitutional limits on federal authority by requiring most Americans to buy medical insurance. F
NEW YORK Investors could be excused for avoiding health insurance and hospital stocks as a U.S. Supreme Court decision nears on President Barack Obama's healthcare overhaul law - an outcome that could send the companies' shares down 10 percent or mor
WASHINGTON The legal fate of President Barack Obama's signature healthcare law will likely come down to two Republican appointees on the U.S. Supreme Court -- Chief Justice John Roberts and Justice Anthony Kennedy. That would be a familiar role for K
n">A U.S. law requiring large graphic health warnings on cigarette packaging and advertising does not violate the free speech rights of tobacco companies, a federal appeals court ruled on Monday. Cigarette makers had sued to stop the U.S. Food and
WASHINGTON The Supreme Court doesn't have to strike down all of President Barack Obama's healthcare law to leave his plan to extend healthcare coverage to millions of uninsured Americans in a state of political turmoil. If the high court opted only t
WASHINGTON President Barack Obama could seek common ground with Republicans in the looming battle over Medicare spending by broadening the debate over entitlement reform to encompass the spiraling healthcare costs that confront a wide range of Americ
WASHINGTON The Supreme Court will likely reject a request to speed up a ruling on President Barack Obama's healthcare overhaul law, legal and financial analysts said. The justices on Friday are scheduled to consider Virginia's request seeking to bypa
WASHINGTON U.S. courts have authority to decide whether President Barack Obama's healthcare law is valid under the Constitution, his attorney general told a court on Thursday in a further bid to defuse a controversy Obama ignited earlier this week. A
WASHINGTON U.S. courts have authority to decide whether President Barack Obama's healthcare law is valid under the Constitution, his attorney general told a federal court on Thursday in a further bid to defuse a controversy Obama ignited earlier this
WASHINGTON The Supreme Court refused on Monday to speed up a ruling on President Barack Obama's healthcare overhaul, his signature domestic achievement that has provoked a fierce political and legal battle. The justices rejected the state of Virginia
WASHINGTON A Michigan-based legal group on Wednesday asked the Supreme Court to review and overturn a decision that found President Barack Obama's signature healthcare law constitutional. In the first of several appeals likely to reach the high court
WASHINGTON The Obama administration on Wednesday asked the U.S. Supreme Court to back the centerpiece of Barack Obama's sweeping healthcare overhaul -- the requirement that all Americans have health insurance. The appeal was largely expected as a hig
n">An experimental sleep-disorder drug made by Vanda Pharmaceuticals Inc is safe and effective enough to warrant approval, a U.S. Food and Drug Administration review found, sending the company's stock up as much as 88 percent on Tuesday. The repor
WASHINGTON The U.S. Supreme Court on Monday declined to take up preliminary appeals brought by Roman Catholic groups that want an exemption from part of President Barack Obama's healthcare law requiring employers to provide insurance that covers cont
WASHINGTON The U.S. Justice Department asked a federal appeals court on Friday to reconsider its July 22 ruling that poses a major setback to the Obamacare health insurance overhaul as it could limit the availability of federal health insurance subsi
WASHINGTON The U.S. Supreme Court on Wednesday is set to wade into Teva Pharmaceutical Industries Ltd's fight over patent protections for Copaxone, its top-selling multiple sclerosis drug, in one of the most important business cases of the justices'
GENEVA The World Health Organization promised on Saturday that it would publish a full review of its handling of the Ebola crisis once the outbreak was under control, in response to a leaked document that appeared to acknowledge it had failed to do e
WASHINGTON The U.S. Supreme Court agreed on Friday to hear a legal challenge to a key part of the Obamacare health law which, if successful, would deprive millions of Americans of tax-credit subsidies to help them afford health insurance coverage. In
LOS ANGELES The California Supreme Court on Thursday rejected limits on medical marijuana imposed by state lawmakers, finding that people with prescriptions for pot can have and grow all they need for personal use. The high court ruled lawmakers impr
- 08-061Micardis40mg / für hohe BP / Upgrade auf 80mg / 2 Monate Husten um gleichen Zeitraum entwickelt /?
- 05-112Eine Reise zu den größten Weinmesse der Welt: Vinitaly und Mehr
- 10-223Ein Ende schneller Genehmigungen für Krebs-Medikamente? (Morning Read)
- 01-294Hat jemand auf Dronedaron, war von ihm weg genommen und hatte wieder Probleme?
- 05-065Vier-Wege-Nasenspray - warum hat 4-Wege-Nasensprays nicht mehr verkauft werden. wird es zurückgeben?
- 07-026Warum die "Wahlfreiheit" Argument ist ein automatischer Gewinn für Big Soda
- 11-237Die Autismus-Fad Parade geht weiter
- 05-218Haben Sie den Menschen helfen, ihre Medikamente, die ich nehmen demopresson für Diabetiker insipidus mit Gewährung?
- 10-179Chlorthalidone - Ich habe dies für Ödeme nehmen, und ich habe sehr müde gewesen. Einschlafen?
- 10-211Tests show flu spreads from schools
- 10-222Wie lange Nebenwirkungen zuletzt nach Escitalopram 20mg kommen aus?
- 09-193Was ist die übliche Dosierung für Heidelbeere Kapseln?
- 10-224Medical cornhole 2011: Gesundheitswesen Architekten Perspectus bauen ihren Sieg
- 12-115Ist Effexor als effecetive wie Cymbalta für numness von perifeal Neuropathie verursacht?
- 12-136GROSSES PROBLEM! Mein Schmerz doc fiel mir. Huch ... Ich sehe Probleme am Horizont. Ich wusste, das würde?
- 04-287Prinzip # 10: Ausbildung ist die höchste Form der Nächstenliebe
- 09-128Ist Verstopfung normale während Prevacid zu nehmen?
- 02-149Eine Reise mit Spielzeug
- Wenn IntElect Medical gewinnt, ist Ohio verlieren?
- Jumpstart gewinnt nationalen wirtschaftlichen Entwicklung preis
- in den USA 60 Millionen Menschen negativ durch jemand anderes Pathologie Betroffene
- Linked Salmonellen-Ausbruch auf Gurken sickens 73
- Hat entalkoholisiertem Wein Nutzen für die Gesundheit?
- Hat Kontrolle Paxil Panikattacken?
- Was sind die Ursachen Fatigue bei Multipler Sklerose?
- KKR mulls teaming with Japan state fund on Panasonic unit stake: media
- Der Erneuerungsplan: Ein neues Paradigma in der Heilung
- Ich war vor kurzem vor mit tendonitis ca. 2 Wochen diagnostiziert. Ich hatte Schmerzen in meinem Knie wurde mit?
- Ein zehn Jahre alter Junge, den ich für mich kümmern scheint Symptome von roid Wut auf Genotropin zu erleben?
- Bei der Verwendung von TriNessa und Sie verpasst versehentlich eine Pille würden Sie bluten? Wenn ja, wie lange?
- Jeder Übergang von ZOLOFT 2 St.Johns Warze?
- Ich möchte die beste Zeit, zu wissen, meine Medikamente zu nehmen?
- Pacific Yew Pflanze: Natürliche Heilmittel oder giftige Krebsmedikament?
- Ich ging durch meine erste Packung von errin und ich war wegen meiner Zeit ein oder zwei Tage vor und ich noch?
- Der Fall für die obligatorische GVO-Kennzeichnung - auch wenn Sie in begrenzten Regierung und dem freien Markt glauben
- Obamacare Themen ganze Nation zu Lösegeldforderungen von Zwangs Regierung
- TORONTO Canadian health officials said on Wednesday that the H1N1 flu outbreak might have reached its peak in Canada, but cautioned that the fight is not yet over. David Butler-Jones, Canada's chief public health officer, said that while some areas o
- Ich habe für 2 Wochen auf abilify gewesen, 2 mg. mein Doc gestern Abend zu mir meine Dosis auf 5 mg .. worden Schütteln und müde den ganzen Tag wollten. Hatte einen bipolaren Zusammenbruch ersten Mal in zwei Wochen früher .. Es scheint, die 2 mg funk
- Medtronic Inc. (NYSE: MDT) hat in Europa eine Reihe von implantierbaren Kardioverter-Defibrillatoren ins Leben gerufen, die eine unnötige Schocks reduzieren sollen zu. Die companyâ € ™ s Protecta ICDs und kardialen Resynchronisationstherapie - Geräte
- n">Many tasks can be tackled more quickly now than 50 years ago, but delivering a baby naturally it seems is not one of them, according to a U.S. government study. Compared with the 1960s, U.S. women have in recent years spent two to three hours l
- Hallo alle. Hoffnung, die Menschen fangen die Nachrichten in Bezug auf die Arsengehalt in Reis, der in den USA und der Gefahr, die sie für Säuglinge, beeinträchtigtem Immunsystem und Menschen mit häufigen Konsum stellt angebaut wird. Offenbar weiß Re
Mein Seroquel XR in der Nacht hat scheinen völlig arbeiten zu beenden. Verwendet schläfrig zu werden und rechts fallen?... Zu schlafen und die ganze Nacht schlafen. Jetzt nicht sleeply und die ganze Nacht aufwachen. Gerade erst eröffnet eine neue Flasche und scheint zufällig. Jeder sonst dieses Problem haben? Vielen Dank ----schneiden---- In Antwort auf Delila bei 20
- BRUSSELS The European Union's executive Commission is to propose larger health warnings on cigarette packets and a total ban on flavorings such as menthol, a draft revision of EU tobacco rules seen by Reuters showed on Monday. The proposals stop shor
- Credit: Africa Studio / Shutterstock.com Menschen, deren Ernährung enthalten moderate Mengen an Natrium gesündere Herzen haben und länger leben als diejenigen, die zu viel verbrauchen oder zu wenig von dem Mineral, schlägt neue Forschung. In einer gr
- [Youtube] lUtnas5ScSE [/ youtube] Letzte Woche Chipotle veröffentlicht diese als Marketing-Kampagne kurz animiert. Seiten wie The New York Times, NPR, Schiefer, etc. veröffentlicht das Video, die meisten mit glühenden Vermerke (Bruce Horovitz bei USA
- ein Ernährungstagebuch zu halten, ist eine besonders leistungsstarke Praxis, die Ihre Ernährung verwandeln kann. Nur durch Ihr Maß an Bewusstsein über das Essen und Ihre Essgewohnheiten zu erheben, kann ein Ernährungstagebuch hilft Ihnen mehr gesund
- Ich habe meine Tochter 3/4 TL brovex, sie Asthma hat und jetzt über ihre Kehle beschwert?
- Hat jemand schon einmal wunde Stellen im Mund vom Kauen nicorrette Kaugummi für longser bekommen als auch angenommen, wie?
- Ist hypertention tödlich?
- Generisches Cymbalta - Ist es verfügbar?
- Kann ein Apotheker gesetzlich mein Rezept halten, auch wenn ich dafür wieder fragen? Ich lebe in Kalifornien?
- Hat noch jemand irgendwelche Probleme mit der Paxil ihren Blutzucker einen Typ-2-Diabetiker IM stört?
- Ultraschall Firma erwägt Research Triangle Park HQ vor Gericht pharma
- Psychische Gesundheit, Suchthilfe-Gruppen zu astroturf vierten Juli Paraden
- Langzeit Xifaxan Einsatz?
- Brain Master Switch Entdeckt